Vesico-Ureteral Reflux Clinical Trial
Official title:
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)
In this research study the investigators want to study a safe, radiation-free technique known as contrast-enhanced ultrasound that may improve the ability to diagnose or evaluate renal scarring compared to regular ultrasound. This technique requires injection into a vein of a small amount of contrast material called Lumason. Contrast material is a type of dye that helps the investigators image the structures in the body more clearly. If this technique is successful, the need for DMSA studies may be avoided to diagnose or evaluate kidney scarring. DMSA is a more expensive test, causes radiation exposure, may require sedation and/or injection of contrast agents with the potential to cause allergic reactions.
Status | Not yet recruiting |
Enrollment | 70 |
Est. completion date | June 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 35 Years |
Eligibility | Inclusion Criteria: - patients older than or equal to 6 months and less than or equal to 35 years old and scheduled for Boston Children's Hospital (BCH) DMSA scan to evaluate renal function and/or renal scarring Exclusion Criteria: - patients with significant congenital renal anatomical abnormalities including horseshoe kidney, kidney malrotation, and multicystic dysplastic kidney (MCDK). Patients with severe cardio-pulmonary diseases will also be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | Boston Children's Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston Children's Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance of CEUS result and comparison to DMSA | DMSA will be used as gold standard to evaluate CEUS test performance. Sensitivity and specificity of CEUS renal scarring detection will be calculated accordingly. Bivariate and multivariate analyses will be completed to compare patient characteristics between those with good and poor CEUS performance to investigate if CEUS performs better in patients with specific covariates | 3 months after final participant completes participation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02271035 -
A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children
|
Phase 4 | |
Completed |
NCT04798443 -
Endoscopic Injection of Dextranomer/Hyaluronic Acid Versus Ureteral Reimplantation In Treatment of Vesicoureteral Reflux
|
N/A | |
Completed |
NCT05864131 -
Effects of Parental Holding on Pain Response in Young Children During Cystometry
|
N/A | |
Completed |
NCT02204917 -
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
|
Phase 1/Phase 2 | |
Completed |
NCT01297673 -
Reflux in Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction
|
N/A | |
Recruiting |
NCT00367159 -
Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children
|
Phase 3 | |
Withdrawn |
NCT02986477 -
Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration
|
N/A | |
Active, not recruiting |
NCT04251988 -
VR to Reduce Pain and Anxiety During GU Scans
|
N/A |